Author

Carlos Dueñas

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

Clinical Outcomes of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People Living With HIV and Low-Level Viraemia.

IntroductionLow-level viraemia (LLV) in people living with HIV (PLWH) remains a clinical challenge, associated with increased risk of virological failure, immune dysregulation, and chronic inflammation. Bictegravir/emtricitabine/tenofovir alafenamide is a single-tablet regimen with a high genetic barrier to resistance,...

I. de los Santos, Guillermo Pousada, C. Galera et al. · Journal of the International... · 0 citations

Open access Sep 2026

Integrated Immune Profiling Identifies Treatment-Associated Immune Patterns in Patients with B‑Cell Hematological Malignancies

Integrated serological and cellular profiling provides a scalable framework for characterizing an immune fingerprint with potential prognostic value in patients with B-cell hematological malignancies and supports further investigation of immune monitoring approaches in larger longitudinal cohorts.

Carlota Arias-Hidalgo, J. Hernández-Vázquez, C. Teodosio et al. · Journal of Proteome Research · 0 citations